PERSPECTA

News from every angle

Back to headlines

Novo Nordisk's Ozempic price cut boosts sales in India

Novo Nordisk has seen a significant increase in sales of its obesity drug, Ozempic, in India following a recent price reduction.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.